반응식
[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[C:6]([OH:18])=[C:7]3[C:15](=[O:16])[NH:14][NH:13][C:12](=[O:17])[C:8]3=[N:9][C:10]=2[CH:11]=1.[OH-].[OH:20][CH2:21][CH2:22][N+:23]([CH3:26])([CH3:25])[CH3:24]>CO>[OH:20][CH2:21][CH2:22][N+:23]([CH3:26])([CH3:25])[CH3:24].[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[C:6]([OH:18])=[C:7]3[C:15](=[O:16])[NH:14][NH:13][C:12](=[O:17])[C:8]3=[N:9][C:10]=2[CH:11]=1참가 물질
4
실험 절차
To a suspension of 7-bromo-2,3-dihydro-10-hydroxypyridazino[4,5-b]quinoline-1,4-dione (0.600g, 1.95 mM) in methanol (20 mL) was added choline hydroxide (0.24 g, 1.98 mM, 45% solution in methanol). The resulting solution was concentrated and the solid yellow residue was recrystallized from ethanol to provide (0.62 g, 78%) the title compound as yellow crystals, mp 227.5°-228.5° C.
후처리
- concentrationThe resulting solution was concentrated
- customthe solid yellow residue was recrystallized from ethanol
출처 및 근거
- ORD 기록
- ord-94d9309832e348ba9c46db768414dfd5
- 출처 데이터셋
- uspto-grants-1998_03
- 특허 번호
- US05733910
연결된 노트
불러오는 중…